Singapore markets open in 7 hours 17 minutes

Straits Times Index
3,343.35
+11.65(+0.35%)
S&P 500
5,483.80
+5.90(+0.11%)
Dow
39,233.64
+105.84(+0.27%)
Nasdaq
17,866.59
+61.43(+0.35%)
Bitcoin USD
61,771.41
+684.33(+1.12%)
CMC Crypto 200
1,289.21
+23.07(+1.82%)

RPTX Oct 2024 7.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.3500

0.0000

(0.00%)

As of 10:10AM EDT. Market open.

Loading interactive chart…

Business Wire
Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI
CAMBRIDGE, Mass. & MONTREAL, June 26, 2024--Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI
Business Wire
Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial
CAMBRIDGE, Mass. & MONTREAL, June 10, 2024--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s camonsertib monotherapy non-small cell lung cancer (NSCLC) expansion of the TRESR clinical trial.
Zacks
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Repare (RPTX) rises 14% as the FDA grants Fast Track designation to its investigational lunresertib/camonsertib combo to treat adult ovarian cancer patients in the United States.